| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,293 |
28,262 |
$984K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
29,935 |
26,342 |
$360K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,387 |
3,963 |
$214K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,151 |
2,794 |
$136K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,957 |
5,864 |
$71K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,842 |
2,331 |
$59K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,741 |
5,629 |
$7K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
31 |
27 |
$57.82 |